Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, disease, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Not stated	2026-07-24		NCT03957252

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alberta Cancer Foundation	4
Alberta Innovates Health Solutions	8
Alberta Precision Laboratories	3
Alberta Prostate Cancer Research Initiative, APCaRI	1
Kipnes Urology Centre	1
Motorcycle Ride for Dad	2
Nanostics	2
Prostate Cencer Centre, Calgary	1
University Hospital Foundation - The Kaye Fund Competition	1

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Johns Hopkins University	Baltimore	United States	49
Kipnes Urology Centre	Edmonton	Canada	2
Prostate Cancer Centre	Calgary	Canada	12